Literature DB >> 66606

Serum-25-hydroxycholecalciferol in hyperthyroidism.

L Mosekilde, B Lund, O H Sorensen, M S Christensen, F Melsen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 66606     DOI： 10.1016/s0140-6736(77)92995-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Postoperative tetany in Graves disease: important role of vitamin D metabolites.

Authors:  H Yamashita; T Murakami; S Noguchi; M Shiiba; S Watanabe; S Uchino; H Kawamoto; M Toda; N Murakami
Journal:  Ann Surg       Date:  1999-02       Impact factor: 12.969

2.  Serum fibroblast growth factor 23 and mineral metabolism in patients with euthyroid Graves' diseases: a case-control study.

Authors:  C-H Lin; C-K Chang; C-W Shih; H-Y Li; K-Y Chen; W-S Yang; K-S Tsai; C-Y Wang; S-R Shih
Journal:  Osteoporos Int       Date:  2019-08-05       Impact factor: 4.507

3.  Thyroid disorders and bone mineral metabolism.

Authors:  Dinesh Kumar Dhanwal
Journal:  Indian J Endocrinol Metab       Date:  2011-07

4.  Bone mineral density in patients of Graves disease pre- & post-treatment in a predominantly vitamin D deficient population.

Authors:  Viveka P Jyotsna; Abhay Sahoo; Singh Achouba Ksh; V Sreenivas; Nandita Gupta
Journal:  Indian J Med Res       Date:  2012       Impact factor: 2.375

5.  No Association between 25 (OH) Vitamin D Level And Hypothyroidism among Females.

Authors:  Imad R Musa; Gasim I Gasim; Sajjad Khan; Ibrahim A Ibrahim; Hamdi Abo-Alazm; Ishag Adam
Journal:  Open Access Maced J Med Sci       Date:  2017-03-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.